MedPath
TGA Approval

CSL US ZEMAIRA human alpha1-proteinase inhibitor 1000 mg powder for injection vial with diluent vial (356861)

356861

CSL US ZEMAIRA human alpha1-proteinase inhibitor 1000 mg powder for injection vial with diluent vial

CSL Behring (Australia) Pty Ltd

March 16, 2021

Medicine

Medicine

Active

Listed - Exempt

Active Ingredients

Alpha-1-proteinase inhibitor

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.